Back to search

University of Ioannina

Επανεκτίμηση του επιπολασμού και του κινδύνου εκδήλωσης Σακχαρώδη Διαβήτη τύπου 2 σε γενικό πληθυσμό της περιοχής Έβρου

Abstract

dc:description

The increase in the prevalence of Type 2 Diabetes Mellitus (DM T2) is a major public health problem. The purpose of this dissertation was to re-evaluate the prevalence and risk of DM T2 in the general population of the region of Evros.For this purpose, in the year 2015-2016, a random sample of 541 adults (men: 239 individuals and women: 302, SD : 64.1±8,0) from the villages (Loutra, Antheia, Areistino, Doriko and Nipsa) of the Evros area was studied. All participants voluntarily completed a questionnaire. The questionnaire included questions related to disease manifestations and gave the participants points and overall score (Finnish Type 2 Diabetes Risk Score) and were tested for somatometric parameters (body weight, height, measurement of abdomen and hip circumference), blood pressure (BP), Fasting Glucose (FG) and Postprandial Glucose (PG) with reflector. From the completion of the questionnaire with the self-report of the disease, 139 people (25,7%) stated that they had Type 2 Diabetes (Known as DM T2). No laboratory examination was performed on these individuals. The remaining 402 people with undiagnosed DM T2, depending on the overall score, were classified into 5 levels of risk of event DM T2 (Low: score < 7, Fairly low: score 7 - 11, Medium: score 12 - 14, High: score 15-20 and Very high level: score ≥ 20). According to the criteria of the study protocol, individuals with high (score 15-20) and very high risk (score ≥ 20) of DM T2 manifestation and people with FG ≥ 100 - 125 mg/dl and / or PG > 140 mg/dl, were called for laboratory testing for DM T2, which in total were 214 people. Of these, 206 individuals turned up (38%) and underwent the Oral Glucose Tolerance Test (OGTT) for the estimation of the prevalence of the Unknown DM T2 and Prediabetes. Also, for the reassessment of the prevalence of DM T2 for the village of Loutra the analysis (n = 198) of the data of the previous study "Loutros 1" (year 2007-2008) was carried out while, from the data of the present study, a separate analysis was performed of the participants of the village Loutra (n = 228) "Loutros 2". Following the same methodology, with the self-report of the disease, 31 people i.e. 15.7% (in the year 2007-2008) and 70 people, ie. 30.7% (in the year 2015-2016) stated that they had DM T2. In these individuals, no laboratory test was performed. Also, cases with undiagnosed DM T2 were 167 people (84,3%) in the study "Loutros 1" and respectively 158 people (69,3%) in the study "Loutros 2". According to the criteria of the protocol of the older study "Loutros 1", people with values FG ≥ 126 mg/dl or PG = 100-125 mg/dl and total Score ≥ 20, were subjected to laboratory testing. The people who met the criteria were 38 individuals (19,2%) in the study "Loutros 1" and 69 individuals (30,3%) in the study "Loutros 2", who underwent OGTT for the estimation of the Unknown DM T2 and Prediabetes.Also, in the 206 individuals who met the criteria of the present study, the lipid profile, the incidence of Metabolic Syndrome and the cardiovascular risk based on apolipoproteins were assessed.The estimation of the prevalence of DM T2 was performed by the method of self-report for the Known DM T2 and the diagnosis of the Unknown DM T2 according to the criteria of WHO. For the diagnosis of DM T2 and Prediabetes (Impaired Glucose Tolerance – IGT and Impaired Fasting Glucose – IFG), after 3 days of preparation (high carbohydrate consumption), a total of 206 glucose 75 g (OGTT) loading tests were performed and venous blood sampling in two times (at times 0’ and 120’), with the arrival of individuals after an overnight fast (8 hours). The same methodology was followed in the study "Loutros 1". The laboratory test was performed using their social security registration number. The analysis of the samples was done at the University General Hospital of Alexandroupolis. In the 206 individuals (90 men i.e 42,7% and 116 women i.e 57,3%) who met the criteria of the present study, a lipid test for Cholesterol - CHOL, HDL-CHOL, LDL - CHOL and Triglycerides (TG) and a test for the apolipoproteins Apo-A1, Apo-B and Lp (a) were performed. In addition, the incidence of Metabolic Syndrome was assessed according to WHO 1999, NCEP III 2001, NCEP-R 2004, AACE 2002 and IDF 2006 criteria. The assessment of cardiovascular risk was made by calculating the atherosclerotic index Apo-B / Apo -A1 and the values of Lp (a).The results of the study showed: 1.For the region of Evros, in the total study sample of 541 individuals, prevalence DM T2: 29.6% (Known DM T2: 25.7% + Unknown DM T2: 3.9%) and Prediabetes 10,9% (IGT: 5,7%, IFG: 5,2% and IGT + IFG: 6,3%) the prevalence of DM T2 differed according to age of the population and was higher 80% in the age group ≥ 65 years for the year 2015-2016. 2.From the sample of 228 people for the village of Loutra prevalence DM T2: 34.6% (Known DM T2: 30.7% + Unknown DM T2: 3.9%) and Prediabetes 26,2% (IGT: 3,1%, IFG: 23,2% and IGT + IFG: 0,4%) for the year 2015-2016. 3.From the sample of 198 people for the village of Loutra in the year 2007-2008, a prevalence of DM T2 was estimated at 21.6% (Known DM T2: 15.6% + Unknown DM T2: 6%) and Prediabetes:13,1% (IGT: 11,6% and IFT: 1,5% and IGT + IFG:8,6%).4.For the village of Loutra increased risk of occurrence of DM T2: 58,9% at the end of 8 years. 5.For cardiometabolic risk factors in the sample of 541 individuals, the results showed: a)Obesity: 52.7% of the total study sample were classified as obese with Body Mass Index (B.M.I.) ≥ 30 kg / m2 and by gender men: 54.4% and women: 51% with men being 3.4% ahead of these women, as overweight: B.M.I. 25-30 kg/ m2 33.2% (and by gender men: 32.6% and women:33.8% with women leading by 1.2% and as normal / underweight: B.M.I. <25kg / m2 14.1% and by gender men: 13% and women:15.2% with women being 2.2% ahead of men. Central Obesity: for circumference measurements for men ≥ 102 cm: 58.6% and for women ≥ 88 cm: 86.8%. And for circumference measurements for men ≥ 94 cm: 85.8% and for women ≥ 80 cm: 97,7%. Adipose tissue distribution: By waist/hip ratio (WHR) for men WHR ≥ 0.90:95.4% and for women WHR ≥ 0.85: 92% and respectively, with values for men WHR ≥ 1.0: 50.6% and for women WHR ≥ 0.90:72.8% were found to have central adipose tissue distribution b)Hypertension: 66.9% of the sample had hypertension, with 58.8% under antihypertensive treatment. Of the remaining people from the measurement of Blood Pressure (BP) were found with increased values of Systolic (BP) ≥ 140 mm Hg: 42.6% and of these 19.7% with increased values of Diastolic (BP) ≥ 90 mmHg.6.Lipid profile in 206 individuals: at limit values CHOL 200 - 239 mg/dl were 32.5% and 13.6%, at high values CHOL ≥ 240 mg/dl. 10,2% of women in undesirable HDL - CHOL values < 45 and 3.4% of men with HDL - CHOL values <35 while at marginally high levels of LDL - CHOL ≥160 mg/dl :5,9%. Also, a total 19.5% of people were found to have hypertriglyceridemia of which 18% with TG levelsT200 - 499 mg/dl: and 1.5% with severe hypertriglyceridemia (TG ≥ 500 mg/dl).7.Metabolic Syndrome in the sample of 206 people: High incidence ( 92.2%) with Metabolic Syndrome using the criteria of Metabolic Syndrome AACE 2002, against the other criteria. And 100% correlation of the diagnosis of Metabolic Syndrome against AACE 2002 with the diagnostic results of the Unknown DM T2, as the total of 19 people with Unknown DM T2 is recognized to have Metabolic Syndrome. Also, 90% correlation between the diagnosis of Metabolic Syndrome and IGT as the 28 people with IGT out of the total of 31 diagnosed with IGTware identified to have Metabolic Syndrome.8.Estimation of indicators for the occurrence of cardiovascular diseases in the sample of 206 people: A total of 108 people (52.43%) were estimated to be at a high level of risk of cardiovascular disease, based on the atherosclerotic index Apo-B / Apo-A1 at 19.43% of the sample (40 people: 19 men: 21.1% of men) and 21 women (18.1% of women) and based on Lp (a) values 33% (68 people).The results show that the data of the present study for the prevalence of DM T2 agree with IDF data. Nevertheless, the increasing trend of DM T2 disease becomes apparent in the study as well as other studies throughout Greece. Regarding the cardiometabolic risk factors in the population group of obesity, it is classified above ½ of the study population, a fact which is supported by the nationwide data from other studies, in contrast to the results of the study, which show that men are at the forefront of obesity and women are overweight. With increased abdominal fat deposition for both sexes in the study population and almost twice the increase in central obesity in the female population compared to data from other studies. Also, over ½ of the study population is classified at high levels of hypertension prevalence, data that support the nationwide data from other studies. In addition, from the BP measurements, significant percentage of Unknown hypertension was detected in the study population. Regarding the lipid profile of the population, there is an increase in hypercholesterolemia (CHOL), an increase in undesirable levels of HDL - CHOL < 45 in women compared to these men HDL - CHOL < 35, which evidence is contrasting with the previously limited Greek data. Furthermore, ¼ of the study population is classified as marginally high and high LDL - CHOL levels. Also, a high occurrence of the parameters of the Metabolic Syndrome was found in the study population, a fact which supports the nationwide data from other studies. In addition, a high correlation was found between the criteria of the Metabolic Syndrome (AACE, 2002) and the diagnosis of DM T2. In addition, the study provides data for independent prognostic markers of increased atherosclerotic load from the apolipoproteins Apo-B, Apo-A1 and Lp (a) and calculates the cardiovascular risk, based on the atherosclerotic index Apo-B / Apo-A1 and values of Lp (a), data that have not been studied more widely for the Greek population.In summary, the present study has new data on the prevalence of DM T2 as well as the high risk of disease and related cardiovascular risk factors for the region of Evros, which are necessary for the organization of targeted prevention and treatment policies.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ventouri, Sarantoula
  • Βεντούρη, Σαραντούλα

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/51558

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ventouri, Sarantoula; Βεντούρη, Σαραντούλα. Επανεκτίμηση του επιπολασμού και του κινδύνου εκδήλωσης Σακχαρώδη Διαβήτη τύπου 2 σε γενικό πληθυσμό της περιοχής Έβρου. University of Ioannina, 2021. http://hdl.handle.net/10442/hedi/51558